Viennese hospitals to improve cancer treatment with Elekta equipment and software

VIENNA, Austria, July 18, 2016 - The Vienna Hospital Association (Wiener
Krankenanstaltenverbund) has chosen to treat its cancer patients with advanced
solutions from Elekta’s (EKTA-B.ST) radiation therapy and software portfolio.
The deal will include four Versa HD and two Elekta Infinity linear accelerators,
brachytherapy afterloaders, MOSAIQ oncology information system and Monaco
treatment planning system, as well as long-term service contracts.
The equipment and software will be installed at two new radiation oncology
departments situated in Vienna: Hietzing Hospital (KHR) and Sozialmedizinisches
Zentrum Ost - Donauspital (SZO) in a long-term public-private partnership
contract. All equipment and software will be delivered over the next 24 months.

Ian Alexander, Chief Commercial Officer at Elekta, says that this significant
order underpins Elekta’s leading market position in Austria on a long-term
basis. ”Almost 40,000 people are diagnosed with cancer in Austria each year and
it’s the second most common cause of death in the country. Studies have proven
that radiation therapy is an effective treatment for cancer, even if it cannot
save every patient. We are grateful to be able to make an impact on these
statistics and the patients at the Vienna Hospital Association by improving or
saving lives.”

The Vienna Hospital Association, which includes all hospitals and geriatric
centers in the City of Vienna, is one of the largest hospital operators in
Europe. The Association will purchase the Elekta equipment and software through
VAMED, a leading international company in the field of planning, building, and
managing complex public health care facilities. Elekta will act as a
subcontractor to VAMED.

The order was signed and booked during the first quarter of Elekta’s fiscal year
2016/17. The first shipment of equipment is scheduled for May 2017.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on July 18, 2016.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.